8053:TSESumitomo Corporation Analysis
Data as of 2026-06-17 - not real-time
¥6,547.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Sumitomo Corp trades at a PE ratio of 13.1, well below the industry average of 31.4, and the DCF model suggests an upside of roughly 19.6%. The balance sheet shows abundant cash (over ¥1 trillion) offset by a high debt‑to‑equity ratio, while margins remain modest (gross 20.6%, operating 6.0%) and revenue growth is slightly negative at –0.9%. These fundamentals point to a value‑oriented investment case with limited growth upside but solid cash generation.
On the technical side, the stock sits above its identified support at ¥6,119 and below the 20‑day SMA (¥6,812), with a RSI of 45.6 indicating neutral momentum. The MACD is bearish, volume is decreasing, and the 30‑day volatility is high at ~42%, suggesting short‑term caution despite an overall bullish trend direction. The beta of 0.86 and a “Extreme Greed” sentiment index further temper the risk profile, making a measured approach prudent.
On the technical side, the stock sits above its identified support at ¥6,119 and below the 20‑day SMA (¥6,812), with a RSI of 45.6 indicating neutral momentum. The MACD is bearish, volume is decreasing, and the 30‑day volatility is high at ~42%, suggesting short‑term caution despite an overall bullish trend direction. The beta of 0.86 and a “Extreme Greed” sentiment index further temper the risk profile, making a measured approach prudent.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near support level of ¥6,119
- Bearish MACD histogram
- Decreasing volume and neutral RSI
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to peers (PE 13.1 vs 31.4)
- Upside potential of ~19.6% from DCF
- Strong cash position offsetting high debt
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Diversified conglomerate exposure across industrials and energy transition
- Stable cash generation and solid ROE (~13.5%)
- Value‑oriented pricing with limited dividend expectations
Key Metrics & Analysis
Financial Health
Revenue Growth-0.90%
Profit Margin8.18%
P/E Ratio13.1
ROE13.52%
ROA1.97%
Debt/Equity99.40
P/B Ratio1.7
Op. Cash Flow¥813.5B
Free Cash Flow¥384.4B
Industry P/E31.4
Technical Analysis
TrendBullish
RSI45.6
Support¥6,119.00
Resistance¥7,448.00
MA 20¥6,811.75
MA 50¥6,601.78
MA 200¥5,566.91
MACDBearish
VolumeDecreasing
Fear & Greed Index90.41
Valuation
Fair Value¥1,171.18
Target Price¥7,830.00
Upside/Downside19.60%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.86
Volatility41.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.